Cite
Meister J, Bone DBJ, Knudsen JR, et al. Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nat Commun. 2022;13(1):22doi: 10.1038/s41467-021-27540-w.
Meister, J., Bone, D. B. J., Knudsen, J. R., Barella, L. F., Velenosi, T. J., Akhmedov, D., Lee, R. J., Cohen, A. H., Gavrilova, O., Cui, Y., Karsenty, G., Chen, M., Weinstein, L. S., Kleinert, M., Berdeaux, R., Jensen, T. E., Richter, E. A., & Wess, J. (2022). Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nature communications, 13(1), 22. https://doi.org/10.1038/s41467-021-27540-w
Meister, Jaroslawna, et al. "Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells." Nature communications vol. 13,1 (2022): 22. doi: https://doi.org/10.1038/s41467-021-27540-w
Meister J, Bone DBJ, Knudsen JR, Barella LF, Velenosi TJ, Akhmedov D, Lee RJ, Cohen AH, Gavrilova O, Cui Y, Karsenty G, Chen M, Weinstein LS, Kleinert M, Berdeaux R, Jensen TE, Richter EA, Wess J. Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nat Commun. 2022 Jan 10;13(1):22. doi: 10.1038/s41467-021-27540-w. PMID: 35013148.
Copy
Download .nbib